AWP
NVS icon

Accretive Wealth Partners’s Novartis NVS Stock Holding History

Accretive Wealth Partners’s Portfolio NVS Stock Details NVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-11,133
Closed -$1.02M – 109
2021
Q2 		$1.02M Buy
11,133
+1,609
+17% +$143K 0.73% 56
2021
Q1 		$814K Buy
9,524
+1,069
+13% +$95.9K 0.73% 60
2020
Q4 		$798K Buy
+8,455
New +$739K 0.79% 50

Other funds holding NVS

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aristotle Capital Management
Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Accretive Wealth Partners's NVS Position: Q3 2021 in Review

Accretive Wealth Partners sold out of Novartis (NVS) in Q3 2021, closing a stake of 11,133 shares — an estimated $1.02M sold.

Accretive Wealth Partners first reported a position in NVS in Q4 2020 and held it in 3 quarters. The position peaked at $1.02M in Q2 2021. 1,080 funds tracked by Wall St. Rank hold NVS as of Q3 2021.

  • Accretive Wealth Partners reported no remaining Novartis position as of Q3 2021 after selling out during the quarter.
  • Accretive Wealth Partners sold 11,133 Novartis shares in Q3 2021, an estimated $1.02M.
  • Accretive Wealth Partners first reported a position in Novartis in Q4 2020 and held it in 3 quarters.
  • Accretive Wealth Partners's Novartis position peaked at $1.02M in Q2 2021.
  • 1,080 funds tracked by Wall St. Rank held Novartis as of Q3 2021.

Based on Accretive Wealth Partners's 13F filing for Q3 2021, filed 12 Nov 2021.